Viridian Therapeutics Stock Forecast

Stock Price Forecast

The 12 analysts that cover Viridian Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $38.25, which forecasts a 99.01% increase in the stock price over the next year. The lowest target is $20 and the highest is $61.

Price Target: $38.25 (+99.01%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$20	$38.25	$38	$61
Change	+4.06%	+99.01%	+97.71%	+217.38%

Analyst Ratings

The average analyst rating for Viridian Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	4	6	5	6	6	6
Buy	5	4	6	6	6	6
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	11	12	13	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Richard Law Goldman Sachs	Goldman Sachs	Strong Buy Maintains $41 → $36	Strong Buy	Maintains	$41 → $36	+87.30%	Mar 31, 2026
Laura Chico Wedbush	Wedbush	Buy Maintains $44 → $37	Buy	Maintains	$44 → $37	+92.51%	Mar 31, 2026
Derek Archila Wells Fargo	Wells Fargo	Hold Maintains $29 → $20	Hold	Maintains	$29 → $20	+4.06%	Mar 31, 2026
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $34 → $22	Strong Buy	Maintains	$34 → $22	+14.46%	Mar 31, 2026
Serge Belanger Needham	Needham	Strong Buy Maintains $42 → $32	Strong Buy	Maintains	$42 → $32	+66.49%	Mar 30, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

90.44M

from 70.85M

27.65%

from 70.85M

Revenue Next Year

319.52M

from 90.44M

253.29%

from 90.44M

EPS This Year

-3.81

from -3.32

EPS Next Year

-2.18

from -3.81

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	2.96M	1.77M	314.00K	302.00K	70.85M	90.44M	319.52M
Revenue Growth	182.19%	-40.20%	-82.28%	-3.82%	23,359.93%	27.65%	253.29%
EPS	-6.66	-2.71	-3.91	-3.07	-3.32	-3.81	-2.18
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	18	17

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	226.8M	665.2M
Avg	90.4M	319.5M
Low	18.6M	131.3M

Revenue Growth

Revenue Growth	2026	2027
High	220.1%	635.5%
Avg	27.7%	253.3%
Low	-73.7%	45.2%

EPS Forecast

EPS	2026	2027
High	-2.87	-0.45
Avg	-3.81	-2.18
Low	-4.64	-4.83

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.